Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial) [NA]

View source ↗

Summary

A randomized trial comparing high-intensity rosuvastatin/ezetimibe combination therapy to treat-to-target rosuvastatin monotherapy in patients with peripheral a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRESTOR (Rosuvastatin)
  • Zetia (ezetimibe)

Snippet

Sponsor: Yonsei University | Conditions: Peripheral Artery Disease, Polyvascular Disease | NA | Status: RECRUITING